Old data can transform the future of health care

Patient preference studies (research into what patients value in their treatment) are increasingly used to inform drug development and regulatory approval decisions. But these studies are expensive and time-consuming to conduct. Yet, their results are rarely used beyond their original purpose. Researchers from the University of Twente, in collaboration with international colleagues, identified opportunities to reuse findings from existing studies, thereby improving resource usage during patient-focused drug development.

This post was originally published on this site